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Tacrolimus related neurologic complication after 
pediatric kidney transplantation
Woo-Hyung Kwun
Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea
Recently significant neurotoxicity has been reported with the use of carcineurin inhibitors. An 11-year-old-girl had under-
gone a transplantation of kidney from her mother. On post-operative day 12, hypertension, headache, and left motor weak-
ness (grade I) suddenly occurred. The brain-magnetic resonance imaging and magnetic resonance angiography showed 
acute cerebral infarction at subcortical white matter of the right hemisphere and multiple stenoses of both anterior cerebral 
artery and middle cerebral artery. While stopping tacrolimus treatment, we experienced clinical and radiological 
improvement. So, the neurological complications of this patient seem to have been caused by the use of tacrolimus.
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INTRODUCTION
The increasing use of immunosuppressive agents after 
transplantations has made more complications. Among 
these, neurological side effects of carcineurin inhibitor are 
becoming controversial recently. The neurological change 
related to tacrolimus was first presented as posterior re-
versible leukoencephalopathy in 1996 [1]. Until now, there 
have been many clinical symptoms reported and they are 
referred to various names including posterior reversible 
encephalopathy syndrome. We report an 11-year-old girlʹs 
reversible cerebral infarction and cerebral vascular steno-
sis after using tacrolimus for her kidney transplantation. 
CASE REPORT
An 11-year-old girl with end-stage renal disease had un-
derwent a transplantation of kidney from her mother. Pre‐
transplant donor-specific T- and B-cell cross-matches were 
negative. Initial immunosuppressive treatment consisted 
of tacrolimus (0.2 ng/kg/day orally, target level 15 to 20 
ng/mL), mycophenolate mofetil (1,000 mg twice a day or-
ally), and methylprednisolone (25 mg twice a day orally). 
Tacrolimus levels remained within the target range during 
the first ten days. Renal function was quite good after kid-
ney transplantation. On post-operative day 12, hyper-
tension (160/100), headache, and left motor weakness 
(grade I) suddenly occurred. The brain-magnetic reso-
nance imaging (MRI) and magnetic resonance angiog-
raphy (MRA) findings showed acute cerebral infarction of Woo-Hyung Kwun
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Fig. 1. Brain-magnetic resonance 
imaging and magnetic resonance 
angiography examination on post- 
operative day 12 showed acute 
cerebral infarction at subcortical 
white matter of right hemisphere 
and multiple stenoses of both 
anterior cerebral artery and middle 
cerebral artery.
subcortical white matter of the right hemisphere and mul-
tiple stenosis of both anterior cerebral artery (ACA) and 
middle cerebral artery (MCA) (Fig. 1). Serum tacrolimus 
level at symptom onset was 19.7 ng/mL. Conservative 
treatment was done for several days and tacrolimus con-
tinued with dosage adjusted to maintain a serum level of 5 
to 10 ng/mL. The repeated brain-MRI and MRA scaning 
was performed at post-operative day 19. The findings 
showed newly developed acute cerebral infarction on the 
subcortical white matter of the left hemisphere, cortex of 
the left parietal lobe and mildly improving status of steno-
sis in both ACA and MCA (Fig. 2). This neurological 
change seems to be acute cerebral infarction due to cere-
bral vascular stenosis caused by either vasculitis or vas-
cular spasm, which is highly suspected to be the con-
sequence of tacrolimus. We decided to change from tacro-
limus to cyclosporine. Two days after the change, the cy-
closporine level was 232.64 ng/mL. Afterwards, neuro-
logic symptoms improved and follow-up (post-operative 
day # 29) brain MRI and MRA findings showed an improv-
ing status of multifocal acute infarction and no stenosis of 
either ACA or MCA (Fig. 3). At the 40th postoperative day,  
left motor weakness improved to grade IV, and rehabi-
litation treatment was ongoing.
DISCUSSION
In 1996, Hinchey et al. [1] described a syndrome of acute 
but reversible clinical findings including headache, men-
tal status alteration, seizures, hypertension, and acute vis-
ual changes associated with abnormalities seen on MRI of 
symmetric white matter lesions, usually in bilateral parie-
tal and occipital lobes. They termed this as reversible pos-
terior leukoencephalopathy syndrome. Although it was 
initially thought to affect the subcortical white matter on-
ly, additional studies supported by improved radiologic 
imaging modalities have revealed that the cortical gray 
matter may also be involved. The term “posterior rever-
sible encephalopathy syndrome (PRES)” proposed by 
Casey et al. [2] is widely used recently because it expresses 
its clinical manifestation and radiologic findings appro priately.Neurologic complication, tacrolimus
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Fig. 2. Brain-magnetic resonance 
imaging and magnetic resonance 
angiography examination on post- 
operative day 19 showed newly 
developed acute cerebral infarction 
on subcortical white matter of left 
hemisphere, cortex of left parietal 
lobe and mildly improving status of 
stenosis in both anterior cerebral 
artery and middle cerebral artery.
Fig. 3. Brain-magnetic resonance 
imaging and magnetic resonance 
angiography examination on post- 
operative day 29 showed improved 
status of multifocal acute infarction, 
no stenosis of both anterior cerebral 
artery and middle cerebral artery.Woo-Hyung Kwun
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There have been many reports of this syndrome in the lit-
erature since its initial definition. 
As PRES has become better recognized, many con-
tributing factors have been identified. For example, re-
ports have linked PRES to hypertension, immunosup-
pressive/chemotherapeutic agents, eclampsia, porphyria, 
and renaldysfunction [3,4]. The incidence of neurotoxicity, 
which is one of the major adverse events of calcineurin in-
hibitors, was higher in patients receiving tacrolimus rath-
er than cyclosporine. As both sensory and motor functions 
may be adversely affected, patients thus present with a 
wide range of neurological and psychiatric disorders. 
Mild symptoms include tremor, neuralgia, and peripheral 
neuropathy. Severe symptoms could manifest as psy-
choses, hallucinations, cortical blindness, seizures, cer-
ebellar ataxia, motor weakness, or PRES. MRI is the stand-
ard modality in diagnosing this syndrome. Fluid-attenu-
ated inversion recovery is the most sensitive sequence for 
recognition of cortical and subcortical edema in PRES 
where hyperintense signal alterations are more prevalent 
than in conv entional sequences [5,6]. This girl show ed 
slightly different radiologic findings from those of typical 
PRES what causes vasogenic edema with vasculopathy, 
such as vasoconstriction and vasodilation. This girl's case 
was unique since there was cytotoxic edema with vaso-
spasm. However, we could experience clinical and radio-
logical improvement when we stopped tacrolimus treat-
ment. Thus, the neurological complication of this patient 
seems to have been caused by the use of tacrolimus. PRES 
induced by tacrolimus can usually be diagnosed on the ba-
sis of a characteristic clinical and radiographic pattern and 
is usually reversible by reducing the dosage or with hold-
ing the drug for a few days [7]. Failure to recognize its her-
alding symptoms may potentially increase morbidity in 
organ transplantation. Therefore, careful examination of 
patients receiving immunosuppressive agents was need-
ed to discover this uncommon but good prognostic com-
plication.
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